Good practice in sterilisation

Other OA: closed
⚙ AI-generated summary by qwen3.7-flash+body, 2026-11-13 ⓘ

Guidelines synthesizing evidence on sterilisation highlight tubal ligation failure rates, ectopic pregnancy risks, and potential ovarian cancer reduction while noting that prior endometriosis increases the likelihood of subsequent hysterectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-13 · read from full text ⓘ

This paper reviews clinical guidelines and evidence regarding male and female sterilization procedures, highlighting failure rates, consent issues, and surgical techniques. It notes that women with a history of endometriosis or fibroids are among those most likely to require subsequent hysterectomy following tubal ligation. The text also addresses risks such as ectopic pregnancy and complications from anesthesia, while comparing vasectomy methods for men. Relevance to endometriosis: listed as one indication for future hysterectomy in women who have undergone tubal sterilization, though the paper's main focus is contraceptive surgery.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 9,705 characters · extracted from oa-html · click to expand
Compared with other Western European countries, Great Britain has a high rate of sterilisation, 23% of women of reproductive age or their partners using this method. For New Zealand these figures are even higher, 38% of couples relying on sterilisation.1 Although these figures may fall with the introduction of other long acting contraceptive methods and a shift to delayed childbearing, it is timely to have guidelines from the Royal College of Obstetrics and Gynaecology on such common procedures.2 The guideline on male and female sterilisation synthesises the available evidence and categorises it according to its strength as A (based on adequately designed randomised controlled trials), B (other experimental or observational evidence), or C (consensus among experts).2 The guideline emphasises the specific consent issues for different procedures together with a revised estimate of failure of tubal ligation. Previous studies of failure rates after tubal ligation have often had only one or two years of follow up. The revised pregnancy rate after tubal ligation quoted by the guideline is 1 in 200. The large multicentre study from the Centers for Disease Control, with a 10 year follow up found even higher failure rates—from 18.0 to 18.8 per 1000 procedures.3 Factors associated with increased failure were age under 30 and the use of bipolar coagulation. Improper application of the occlusive devices was also a constant factor in failures in one residency training centre. The recommendation in the guideline of standards for trainees should lead to improved effectiveness of tubal ligation, and its recommendation for a national register and continuing audit should help to clarify long term failure rates. Ectopic pregnancies after tubal ligation are common, accounting for 75% of pregnancies in women who have undergone tubal ligation.4 The shorter duration of symptoms and smaller number of ß human chorionic gonadotrophin measurements in one study (grade B) suggest that doctors may be more likely to suspect an ectopic pregnancy in a woman who has been sterilised.4 However, the higher than normal incidence of ruptured ectopic pregnancies after tubal ligation suggests that women themselves may tend to neglect early symptoms.4 These findings support the advice to inform women about the possibility of an ectopic pregnancy, the symptoms, and the need to seek prompt medical attention. The guidelines point out that there is no substantial long term health risk from sterilisation procedures, and some evidence (grade B) exists of a reduced risk of ovarian cancer after tubal ligation. One recent review suggests this potential benefit should be discussed in preoperative counselling.5 The need for a proper history and examination before sterilisation is emphasised, and a partner history is often useful in decision making. There is no convincing evidence that tubal ligation causes heavy periods, and most women who have been sterilised (>80%) will not undergo future hysterectomy unless they have pre-existing gynaecological disorders. The United States collaborative review of sterilisation showed that women with previous fibroids or endometriosis were most likely to have hysterectomy followed by those with a history of prolonged menstrual bleeding or ovarian cysts.6 In developed countries laparoscopic tubal ligation is usually performed under general anaesthesia. In a review from the United States, however, 39% of deaths from female sterilisation were related to complications of anaesthesia.7 Evidence from randomised trials shows that local anaesthesia will virtually eliminate anaesthesia related complications and death. It is also associated with decreased anaesthesia time, less postoperative pain, faster recovery, and less nausea and vomiting.5 Several randomised studies have shown that spraying topical agents on the tubes reduces postoperative pain. Shoulder tip and pelvic pain after surgery can also be decreased using lignocaine instilled subdiaphragmatically and also into the mesosalpinx5 (grade A evidence). Informed consent is necessary before sterilisation and implies that patients are competent to make a choice. Practitioners often use written consent forms, but they have little legal value and do not replace a full discussion.8 Although not a legal requirement, it is good practice to involve both partners in the decision making. Choice of contraceptive methods has recently been extended for women by the addition of the levonorgestrel intrauterine system. This is seen as reversible contraception with failure rates lower than that of tubal ligation (grade B evidence) and the advantage of decreased menstrual bleeding9 (grade A and B evidence). For many women it will be preferable to tubal ligation or hysterectomy. Men need to be reassured that there is no good evidence that vasectomy affects sexual function.10 A systematic review has also put to rest concerns about an increased risk of prostate cancer after vasectomy.11 Nevertheless, one observational study suggests a twofold increased risk of urolithiasis for men under 45 years for up to 14 years after surgery.8 Increasingly centres in New Zealand and elsewhere are using the non-scalpel method, which has fewer complications than the conventional technique (grade A and B evidence), including lower rates of the potentially serious complications of infection and haematoma.12 The technique is, however, more difficult to learn.13 Controversy still exists on whether a section of vas should be removed; observational studies have shown an increased rate of recanalisation after removal of segments less than 14 mm long,13 so removing at least 15 mm has been suggested. The combination of electrocautery and fascial interposition, without vas segment removal, reduces the failure rate to one tenth that of standard ligation alone (grade B evidence).13 Sperm granuloma, the cause of some pain after vasectomy, is caused by leakage of sperm from the vas. It develops in about 15-40% of men after surgery and may cause pain in 3% of these.13 Thermal cautery may produce a lower incidence of sperm granuloma than electrocautery13 (grade B evidence). The conventional advice of bed rest and scrotal support for 48 hours and avoiding exertion for a week after operation is often disregarded, as is the need for two consecutive sperm analyses showing azoospermia two to four weeks apart. A recent audit in vasectomy centres in New Zealand has shown that 40% of men did not have both counts performed. This finding agrees with other studies and supports the suggestion of sending a reminder to those who have not provided a specimen.11 Alongside these college guidelines, systematic reviews from the Cochrane Collaboration and evidence based abstracting journals are now available for clinicians. Although just publishing the evidence is not enough on its own to change clinical practice, it is a start, and guidelines such as these will help. Acknowledgments HR, in return for speaking, has been reimbursed by Schering NZ, distributor of the levonorgestrel intrauterine device, for attending several conferences. References - 1.Pool I, Dickson J, Dharmalingam A, Hillcoat-Nalletamby S, Johnstone K, Roberts H, editors. New Zealand's contraceptive revolutions. Hamilton: Population Studies Centre, University of Waikato; 1999. New Zealand contraception and sterilisation in an international context. [Google Scholar] - 2.Royal College of Obstetricians and Gynaecologists. Male and female sterilisation. London: RCOG; 1999. [Google Scholar] - 3.Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. Risk of pregnancy after tubal sterilization: findings from the US collaborative review of sterilisation. Am J Obstet Gynecol 1996;1161-8. [DOI] [PubMed] - 4.Hendrix NW, Chauhan SP, Maier RC. Ectopic pregnancy in sterilized and nonsterilized women. A comparison. J Reprod Med. 1998;43:515–520. [PubMed] [Google Scholar] - 5.Ryder RM, Vaughan MC. Laparoscopic tubal sterilization; methods, effectiveness, and sequelae. Obstet Gynecol Clin North Am. 1999;26:83–97. doi: 10.1016/s0889-8545(05)70059-0. [DOI] [PubMed] [Google Scholar] - 6.Hillis SD, Marchbanks PA, Ratcliff Tylor L, Peterson HB. Tubal sterilization and long-term risk of hysterectomy: findings from the United States collaborative review of sterilization. Obstet Gynecol. 1997;89:609–614. doi: 10.1016/s0029-7844(97)00053-7. [DOI] [PubMed] [Google Scholar] - 7.Escobêdo LG, Peterson HB, Grubb GS, Franks AL. Case fatality notes for tubal sterilisation in US hospitals 1979 to 1980. Am J Obstet Gynecol. 1989;160:147–150. doi: 10.1016/0002-9378(89)90108-7. [DOI] [PubMed] [Google Scholar] - 8.Gupta S, Bewley S. Medicolegal issues in fertility regulation. Br J Obstet Gynaecol. 1998;105:818–826. doi: 10.1111/j.1471-0528.1998.tb10225.x. [DOI] [PubMed] [Google Scholar] - 9.Coleman M, McCowan L, Farquhar C. The levonorgestrel-releasing intrauterine device: a wider role than contraception. Aust NZ J Obstet Gynaecol. 1997;37(2):195–201. doi: 10.1111/j.1479-828x.1997.tb02253.x. [DOI] [PubMed] [Google Scholar] - 10.Vasectomy: new opportunities. Baltimore: Johns Hopkins University; 1992. (Population Reports D5:1-23). [Google Scholar] - 11.Bernal-Delgado E, Latour-Perez J, Pradas-Arnal F, Gomez-Lopez Ll. The association between vasectomy and prostate cancer: a systematic review of the literature. Fertil Steril. 1998;70:191–200. doi: 10.1016/s0015-0282(98)00142-3. [DOI] [PubMed] [Google Scholar] - 12.Clenney T, Higgins JC. Vasectomy techniques. Am Fam Physician. 1999;60:137–152. [PubMed] [Google Scholar] - 13.Haws IM, Fergin J. Vasectomy counselling. Am Fam Physician. 1995;52:1395–1399. [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Guidelines as Topic Sterilization, Reproductive Female Humans Informed Consent Male Sterilization, Reproductive Sterilization, Reproductive Sterilization, Tubal Sterilization, Tubal Vasectomy Vasectomy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
pubmed
last seen: 2026-10-08T20:59:21.759586+00:00
unpaywall
last seen: 2026-11-19T08:49:44.633026+00:00